Creabilis Expands Footprint in Europe with Support from High Street Partners
As biotech industry grows, so too does leader in novel therapies for dermatological conditions
ANNAPOLIS, Md.--(BUSINESS WIRE)--Creabilis, a rapidly growing European biotechnology company taps High Street Partners (HSP) to support its geographic expansion, setting up and managing offices in the UK, Switzerland and Luxemburg. HSP is providing software and services to manage operations ranging from international payroll to staffing and compliance. Creabilis is a long-time HSP customer and recently signed a renewal agreement to continue working with HSP.
“We’re experts in developing novel therapies for dermatological conditions, not experts in international hiring, payroll and accounting”
“We’re experts in developing novel therapies for dermatological conditions, not experts in international hiring, payroll and accounting,” said Alex Leech, vice president, head of Finance and Operations at Creabilis. “With HSP as our strategic partner for European expansion, we don’t have to worry about the complexity of opening new locations – managing and operating growing businesses such as ours worldwide is what they do every day.”
As Creabilis opens offices throughout Europe, HSP is supporting the company with consulting services, its cloud-based international business software platform (HSP OverseasConnect®) and on-the-ground expertise. In the UK alone, HSP software and services provide comprehensive support for accounting and financials, providing critical data for external funding and securing tax credits. HSP also assists Creabilis with staff recruiting and helps the company ensure compliance with complex country-specific regulations.
“The biotechnology industry is poised for tremendous growth, and Creabilis is positioning itself to capitalize on that opportunity,” said John Clancy, president of High Street Partners. “We’re focused on building smooth runways into new markets across Europe and beyond, so that Creabilis can take off when it’s time to commercialize.”
Creabilis specializes in the development of innovative topical treatments in dermatology, with a specific focus on pruritus. The company is backed by Sofinnova Partners, Neomed and AbbVie Biotech Ventures Inc., and it is led by an experienced management team with more than 100 years of combined R&D experience in pharma and biotech and more than 20 drug approvals.
About High Street Partners
High Street Partners (HSP) is a premier provider of international business software and services. Its solutions help organizations capitalize on their global growth opportunities by simplifying the management and control of international expansion and operations. With more than a decade of experience working with 600 customers in 110 countries, HSP is a trusted partner that delivers on a promise of International Expansion Simplified. The company offers a flexible, highly integrated solution set, which includes its cloud-based software suite HSP OverseasConnect®, with applications for global payroll, global accounting and global expense management, and HSP Overseas Direct®, a family of managed services including all activities required for establishing and operating an international office or entity. HSP also offers consulting services delivered under the HSP Overseas Advisory banner making it a one-stop-shop for international business. Serving a wide range of industries, commercial enterprises and educational institutions, HSP is committed to helping its customers succeed in their international endeavors. Headquartered in Annapolis, Maryland, HSP has offices worldwide including Boston, Silicon Valley, Toronto, Hong Kong, London, Munich, Shanghai, Singapore, Sydney and Tokyo. For more information, call 1-888-881-6576 or visit www.hsp.com.